Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.245
+0.015 (1.22%)
May 28, 2026, 12:47 PM EDT - Market open
Bionano Genomics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Bionano Genomics stock has a consensus rating of "Buy" and an average price target of $5.00. The average 1-year stock price forecast is 301.61% higher than the current stock price, while the lowest is $4.00 (+221.29%) and the highest is $6.00 (+381.93%).
Price Target: $5.00 (+301.61%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 13, 2026.
Analyst Ratings
The average analyst rating for Bionano Genomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +381.93% | Apr 13, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $4 | Buy | Maintains | $4 | +221.29% | Apr 3, 2026 |
Financial Forecast
Revenue This Year
32.78M
from 28.51M
Increased by 14.99%
Revenue Next Year
44.17M
from 32.78M
Increased by 34.73%
EPS This Year
-2.76
from -4.85
EPS Next Year
-1.13
from -2.76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 34.1M | 45.5M | ||||||
| Avg | 32.8M | 44.2M | ||||||
| Low | 31.2M | 42.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 19.6% | 38.7% | ||||||
| Avg | 15.0% | 34.7% | ||||||
| Low | 9.3% | 29.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.85 | -1.17 | ||||||
| Avg | -2.76 | -1.13 | ||||||
| Low | -2.66 | -1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.